Patents by Inventor John Richard Entwisle
John Richard Entwisle has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11433030Abstract: A dosage form with a first portion and a second portion. The first portion can be an immediate release portion and can comprise a pain reliever, which can be naproxen or naproxen sodium. The second portion can be an extended release portion and can comprise pseudoephedrine or a pharmaceutically acceptable salt thereof and/or dextromethorphan or a pharmaceutically acceptable salt thereof. The dosage form can optionally comprise a stabilizing agent. The dosage form can be adapted to maintain a therapeutically effective amount of pain reliever, pseudoephedrine, or a pharmaceutically acceptable salt thereof, and/or dextromethorphan, or a pharmaceutically acceptable salt thereof, for at least eight hours.Type: GrantFiled: December 16, 2019Date of Patent: September 6, 2022Assignee: The Procter & Gamble CompanyInventors: Mark Edward Stella, John Richard Entwisle, Baltej Ludher, Jonathan E. Clark, Daren K. Anness, Guhan Balan, Andrew Nicholas Carr
-
Publication number: 20200113841Abstract: A dosage form with a first portion and a second portion. The first portion can be an immediate release portion and can comprise a pain reliever, which can be naproxen or naproxen sodium. The second portion can be an extended release portion and can comprise pseudoephedrine or a pharmaceutically acceptable salt thereof and/or dextromethorphan or a pharmaceutically acceptable salt thereof. The dosage form can optionally comprise a stabilizing agent. The dosage form can be adapted to maintain a therapeutically effective amount of pain reliever, pseudoephedrine, or a pharmaceutically acceptable salt thereof, and/or dextromethorphan, or a pharmaceutically acceptable salt thereof, for at least eight hours.Type: ApplicationFiled: December 16, 2019Publication date: April 16, 2020Inventors: Mark Edward Stella, John Richard Entwisle, Baltej Ludher, Jonathan E. Clark, Daren K. Aness, Guhan Balan, Andrew Nicholas Carr
-
Patent number: 10617714Abstract: An effervescent chewable dosage form that comprises a pH neutralization agent, an acid, and an effervescent agent. The chewable dosage form can also further comprise simethicone, a sweetener, and a lubricant. The pH neutralization agent can be calcium carbonate, the acid can be citric acid and the effervescent agent can be sodium bicarbonate.Type: GrantFiled: May 9, 2019Date of Patent: April 14, 2020Assignee: The Procter & Gamble CompanyInventors: Mark Edward Stella, John Richard Entwisle, Jason William Newlon, Christine Louis Naykki
-
Patent number: 10576041Abstract: A dosage form with a first portion and a second portion. The first portion can be an immediate release portion and can comprise a pain reliever, which can be naproxen or naproxen sodium. The second portion can be an extended release portion and can comprise pseudoephedrine or a pharmaceutically acceptable salt thereof and/or dextromethorphan or a pharmaceutically acceptable salt thereof. The dosage form can optionally comprise a stabilizing agent. The dosage form can be adapted to maintain a therapeutically effective amount of pain reliever, pseudoephedrine, or a pharmaceutically acceptable salt thereof, and/or dextromethorphan, or a pharmaceutically acceptable salt thereof, for at least eight hours.Type: GrantFiled: September 25, 2017Date of Patent: March 3, 2020Assignee: The Procter & Gamble CompanyInventors: Mark Edward Stella, John Richard Entwisle, Baltej Ludher, Jonathan E. Clark, Daren K. Aness, Guhan Balan, Andrew Nicholas Carr
-
Publication number: 20190262392Abstract: An effervescent chewable dosage form that comprises a pH neutralization agent, an acid, and an effervescent agent. The chewable dosage form can also further comprise simethicone, a sweetener, and a lubricant. The pH neutralization agent can be calcium carbonate, the acid can be citric acid and the effervescent agent can be sodium bicarbonate.Type: ApplicationFiled: May 9, 2019Publication date: August 29, 2019Inventors: Mark Edward Stella, John Richard Entwisle, Jason William Newlon, Christine Louis Naykki
-
Patent number: 10322144Abstract: An effervescent chewable dosage form that comprises a pH neutralization agent, an acid, and an effervescent agent. The chewable dosage form can also further comprise simethicone, a sweetener, and a lubricant. The pH neutralization agent can be calcium carbonate, the acid can be citric acid and the effervescent agent can be sodium bicarbonate.Type: GrantFiled: June 22, 2018Date of Patent: June 18, 2019Assignee: The Procter & Gamble CompanyInventors: Mark Edward Stella, John Richard Entwisle, Jason William Newlon, Christine Louis Naykki
-
Publication number: 20180296592Abstract: An effervescent chewable dosage form that comprises a pH neutralization agent, an acid, and an effervescent agent. The chewable dosage form can also further comprise simethicone, a sweetener, and a lubricant. The pH neutralization agent can be calcium carbonate, the acid can be citric acid and the effervescent agent can be sodium bicarbonate.Type: ApplicationFiled: June 22, 2018Publication date: October 18, 2018Inventors: Mark Edward Stella, John Richard Entwisle, Jason William Newlon, Christine Louis Naykki
-
Patent number: 10028977Abstract: An effervescent chewable dosage form that comprises a pH neutralization agent, an acid, and an effervescent agent. The chewable dosage form can also further comprise simethicone, a sweetener, and a lubricant. The pH neutralization agent can be calcium carbonate, the acid can be citric acid and the effervescent agent can be sodium bicarbonate.Type: GrantFiled: April 10, 2017Date of Patent: July 24, 2018Assignee: The Procter & Gamble CompanyInventors: Mark Edward Stella, John Richard Entwisle, Jason William Newlon, Christine Louis Naykki
-
Publication number: 20180085317Abstract: A dosage form with a first portion and a second portion. The first portion can be an immediate release portion and can comprise a pain reliever, which can be naproxen or naproxen sodium. The second portion can be an extended release portion and can comprise pseudoephedrine or a pharmaceutically acceptable salt thereof and/or dextromethorphan or a pharmaceutically acceptable salt thereof. The dosage form can optionally comprise a stabilizing agent. The dosage form can be adapted to maintain a therapeutically effective amount of pain reliever, pseudoephedrine, or a pharmaceutically acceptable salt thereof, and/or dextromethorphan, or a pharmaceutically acceptable salt thereof, for at least eight hours.Type: ApplicationFiled: September 25, 2017Publication date: March 29, 2018Inventors: Mark Edward Stella, John Richard Entwisle, Baltej Ludher, Jonathan E. Clark, Daren K. Aness, Guhan Balan, Andrew Nicholas Carr
-
Publication number: 20170209487Abstract: An effervescent chewable dosage form that comprises a pH neutralization agent, an acid, and an effervescent agent. The chewable dosage form can also further comprise simethicone, a sweetener, and a lubricant. The pH neutralization agent can be calcium carbonate, the acid can be citric acid and the effervescent agent can be sodium bicarbonate.Type: ApplicationFiled: April 10, 2017Publication date: July 27, 2017Inventors: Mark Edward Stella, John Richard Entwisle, Jason William Newlon, Christine Louis Naykki
-
Patent number: 9649274Abstract: An effervescent chewable dosage form that comprises a pH neutralization agent, an acid, and an effervescent agent. The chewable dosage form can also further comprise simethicone, a sweetener, and a lubricant. The pH neutralization agent can be calcium carbonate, the acid can be citric acid and the effervescent agent can be sodium bicarbonate.Type: GrantFiled: May 19, 2015Date of Patent: May 16, 2017Assignee: The Procter & Gamble CompanyInventors: Mark Edward Stella, John Richard Entwisle, Jason William Newlon, Christine Louis Naykki
-
Publication number: 20150283064Abstract: An effervescent chewable dosage form that comprises a pH neutralization agent, an acid, and an effervescent agent. The chewable dosage form can also further comprise simethicone, a sweetener, and a lubricant. The pH neutralization agent can be calcium carbonate, the acid can be citric acid and the effervescent agent can be sodium bicarbonate.Type: ApplicationFiled: May 19, 2015Publication date: October 8, 2015Inventors: Mark Edward Stella, John Richard Entwisle, Jason William Newlon, Christine Louis Naykki
-
Publication number: 20150250712Abstract: An effervescent chewable dosage form that comprises a pH neutralization agent, an acid, and an effervescent agent. The chewable dosage form can also further comprise simethicone, a sweetener, and a lubricant. The pH neutralization agent can be calcium carbonate, the acid can be citric acid and the effervescent agent can be sodium bicarbonate.Type: ApplicationFiled: May 19, 2015Publication date: September 10, 2015Inventors: Mark Edward Stella, John Richard Entwisle, Jason William Newlon, Christine Louis Naykki
-
Publication number: 20140371174Abstract: An effervescent chewable dosage form that comprises a pH neutralization agent, an acid, and an effervescent agent. The chewable dosage form can also further comprise simethicone, a sweetener, and a lubricant. The pH neutralization agent can be calcium carbonate, the acid can be citric acid and the effervescent agent can be sodium bicarbonate.Type: ApplicationFiled: June 12, 2013Publication date: December 18, 2014Inventors: Mark Edward Stella, John Richard Entwisle, Jason William Newlon, Christine Louie Naykki